Nucynta ER/Palexia SR（神経因性疼痛）：医薬品市場予測及び分析（～2022）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 8
1.2 List of Figures 8
2 Introduction 9
2.1 Catalyst 9
2.2 Related Reports 9
3 Disease Overview 11
3.1 Clinical Manifestations of Neuropathic Pain – Signs and Symptoms 13
3.1.1 Painful Diabetic Neuropathy 15
3.1.2 Postherpetic Neuralgia 16
3.1.3 Trigeminal Neuralgia 16
3.2 Etiology and Pathophysiology 17
3.2.1 Etiology 18
3.2.2 Pathophysiology 19
4 Disease Management 27
4.1 Diagnosis and Treatment Overview 27
4.1.1 Diagnosis 27
4.1.2 Treatment Overview and Guidelines 34
5 Competitive Assessment 44
5.1 Overview 44
6 Nucynta ER/Palexia SR 49
6.1 Overview 49
6.2 Efficacy 50
6.3 Safety 51
6.4 SWOT Analysis 51
6.5 Forecast 52
7 Appendix 54
7.1 Bibliography 54
7.2 Abbreviations 58
7.3 Methodology 61
7.4 Forecasting Methodology 61
7.4.1 Diagnosed PDN, PHN, and TN Patients 61
7.4.2 Percent Drug-Treated Patients 62
7.4.3 General Pricing Assumptions 62
7.4.4 Individual Drug Assumptions 63
7.4.5 Generic Erosion 63
7.5 Physicians and Specialists Included in This Study 64
7.6 About the Authors 66
7.6.1 Author 66
7.6.2 Global Head of Healthcare 67
7.7 About GlobalData 68
7.8 Disclaimer 68